Development of therapeutic antibodies against SIRPα
Cancer can evade detection by the immune system through interactions with effector cells such as macrophages. CD47 acts as a “don’t eat me” signal for normal cells and is overexpressed in many cancer types. CD47 interacts with SIRPα on macrophages and inhibits phagocytosis. Disrupting the CD47-SIRPα...
Saved in:
Main Author: | Chan, Lynn Xing Hui |
---|---|
Other Authors: | Par Nordlund |
Format: | Final Year Project |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/71532 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
The development of therapeutic antibodies against dengue virus
by: GUNTUR FIBRIANSAH, et al.
Published: (2020) -
Therapeutic Antibodies
by: Chernajovsky, Yuti
Published: (2017) -
Optimization and therapeutic activity of liposome-conjugated monoclonal antibodies against the ErbB family of receptor tyrosine kinases: First step in the development of therapeutic antibody/liposomal anticancer drug combinations
by: Chiu, G.N.C., et al.
Published: (2014) -
ENGINEERING ANTI-ALLERGEN ANTIBODIES AS CANDIDATE THERAPEUTICS FOR ALLERGIC DISEASE
by: CHAN JIN HUI SHERLYNN
Published: (2016) -
Therapeutic Antibodies in Stroke
by: Yu, C.Y, et al.
Published: (2020)